Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flow from operating activities
Net loss	$ (1,810,699)	$ (12,091,303)
Adjustment for non-cash charges and other items:
Depreciation	9,117	5,849
Amortization of deferred debt issuance costs	15,467	0
Stock-based compensation expense	286,600	9,610,554
Change in fair value of derivative instrument	0	213,053
Gain on debt extinguishment	0	(96,145)
Gain on settlement of accounts payable	0	(156,616)
Amortization of debt discount	16,129	0
Total adjustments	(1,483,386)	(2,514,608)
Changes in working capital
Decrease / (increase) in accounts receivable	(812)	25,694
Decrease / (increase) in inventory	(26,217)	0
Decrease / (increase) in prepaid inventory	62,040	0
Decrease / (increase) in prepaid expenses	0	16,485
(Decrease) / increase in trade and other payables	8,141	(67,992)
(Decrease) / increase in accrued expenses	72,617	99,393
(Decrease) / increase in accrued expenses - related party	225,047	(204,121)
(Decrease) / increase in deferred revenue	(19,407)	(25,992)
Total changes in working capital	321,409	(156,533)
Cash flow used in operating activities	(1,161,977)	(2,671,141)
Cash flow from investing activities
Purchase of property and equipment	(9,442)	(50,000)
Cash flow used in investing activities	(9,442)	(50,000)
Cash flow from financing activities
Proceeds from note payable	0	25,000
Proceeds received from related parties	225,165	0
Proceeds from issuance of convertible notes	240,000	0
Proceeds from issuance of stock for cash	669,500	3,300,000
Repayments of note payable	(15,910)	(825,864)
Fees paid in connection with equity offerings	(1,500)	0
Payments to related parties	0	(55,452)
Cash flow provided by financing activities	1,117,255	2,443,684
Decrease in cash and cash equivalents	(54,164)	(277,457)
Cash and cash equivalents at the beginning of the period	70,505	847,430
Cash and cash equivalents at end of the period	16,341	569,973
Non-Cash Investing and Financial Activities:
Conversions of notes and accrued interest	0	269,954
Interest	8,382	0
Taxes	$ 0	$ 0

WEARABLE HEALTH SOLUTIONS, INC. 10-Q